## **Core Concept**
The question pertains to the management of increased intraocular pressure (IOT) in the context of acute anterior uveitis. Acute anterior uveitis, also known as iridocyclitis, is an inflammatory condition affecting the uveal tract of the eye. Management of increased IOT in this setting requires careful consideration of the underlying inflammation and its treatment.

## **Why the Correct Answer is Right**
The correct answer, **D. Acetazolamide**, is appropriate because acetazolamide is a carbonic anhydrase inhibitor that can effectively reduce intraocular pressure (IOP) by decreasing aqueous humor production. In the context of acute anterior uveitis with increased IOP, the use of acetazolamide can help manage the pressure while also considering the need for anti-inflammatory treatment of the uveitis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because [specific reason related to pharmacology or clinical use, e.g., not typically used for IOP management in uveitis].
- **Option B:** This option is incorrect because [specific reason related to pharmacology or clinical use, e.g., may not be suitable due to side effects or mechanism].
- **Option C:** This option is incorrect because [specific reason related to pharmacology or clinical use, e.g., less effective or not indicated for acute IOP management in uveitis].

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in the management of acute anterior uveitis with increased IOP, it's crucial to control the inflammation while also managing the IOP. Acetazolamide can be used to lower IOP, but it's also important to address the underlying inflammation with appropriate anti-inflammatory medications.

## **Correct Answer: D. Acetazolamide**